The role of epithelial β-defensins and cathelicidins in host defense of the lung

Experimental Lung Research

Volumn 33, Issue 10, 2007, Pages 537-542

  Hiemstra, Pieter S ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Airway epithelial cells; Antimicrobial peptides; Cathelicidins; Defensins; Innate immunity

Indexed keywords

BETA DEFENSIN; CATHELICIDIN; COLECALCIFEROL; CYTOKINE; GROWTH FACTOR; POLYPEPTIDE ANTIBIOTIC AGENT;

ADAPTIVE IMMUNITY; ANTIMICROBIAL ACTIVITY; CONFERENCE PAPER; EPITHELIUM CELL; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; INFECTION PREVENTION; INNATE IMMUNITY; LUNG; LUNG DISEASE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN SECRETION; REGULATORY MECHANISM; RESPIRATORY EPITHELIUM;

BETA-DEFENSINS; CATHELICIDINS; HUMANS; IMMUNITY, NATURAL; LUNG; LUNG DISEASES; RESPIRATORY MUCOSA;

EID: 37149044989     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140701756687     Document Type: Conference Paper

References (34)

1. Zasloff M: Antimicrobial peptides of multicellular organisms. Nature. 2002;415:389-395.
2. Ganz T: Antimicrobial polypeptides. J Leukoc Biol. 2004;75:34-38.
3. Smith JJ, Travis SM, Greenberg EP, Welsh MJ: Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell. 1996;85:229-236.
4. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM: Human β-defensin-1 is a salt-sensitive antibiotic in the lung that is inactivated in cystic fibrosis. Cell. 1997;88:553-560.
5. Bals R, Weiner DJ, Meegalla RL, Accurso F, Wilson JM: Salt-independent abnormality of antimicrobial activity in cystic fibrosis airway surface fluid. Am J Respir Cell Mol Biol. 2001;25:21-25.
6. Taggart CC, Greene CM, Smith SG, Levine RL, McCray PB Jr, O'Neill S, McElvaney NG: Inactivation of human {beta}-defensins 2 and 3 by elastolytic cathepsins. J Immunol. 2003;171:931-937.
7. Bucki R, Byfield FJ, Janmey PA: Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum. Eur Respir J. 2007;29:624-632.
8. Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ, Casavant TL, McCray PB Jr: Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc Natl Acad Sci USA. 2002;99:2129-2133.
9. Jia HP, Schutte BC, Schudy A, Linzmeier R, Guthmiller JM, Johnson GK, Tack BF, Mitros JP, Rosenthal A, Ganz T, McCray PB Jr: Discovery of new human beta-defensins using a genomics-based approach. Gene. 2001;263:211-218.
10. Duits LA, Ravensbergen B, Rademaker M, Hiemstra PS, Nibbering PH: Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology. 2002;106:517-525.
11. Zhao R, Wang I, Lehrer RI: Widespread epression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 1996;396:319-322.
12. Harder J, Bartels J, Christophers E, Schröder J-M: A peptide antibiotic from human skin. Nature. 1997;387:861.
13. Garcia JR, Krause A, Schulz S, Rodriguez-Jimenez FJ, Kluver E, Adermann K, Forssmann U, Frimpong-Boateng A, Bals R, Forssmann WG: Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J. 2001;15:1819-1821.
14. Harder J, Bartels J, Christophers E, Schroder JM: Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem. 2001;276:5707-5713.
15. Bensch KW, Raida M, Magert HJ, Schulz-Knappe P, Forssmann WG: hBD-1: a novel beta-defensin from human plasma. FEBS Lett. 1995;368:331-335.
16. Garcia JR, Jaumann F, Schulz S, Krause A, Rodriguez-Jimenez J, Forssmann U, Adermann K, Kluver E, Vogelmeier C, Becker D, Hedrich R, Forssmann WG, Bals R: Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 2001;306:257-264.
17. Huang GT, Zhang HB, Kim D, Liu L, Ganz T: A model for antimicrobial gene therapy: demonstration of human beta-defensin 2 antimicrobial activities in vivo. Hum Gene Ther. 2002;13:2017-2025.
18. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schroder JM, Wang JM, Howard OM, Oppenheim JJ: Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science. 1999;286:525-528.
19. Niyonsaba F, Ogawa H, Nagaoka I: Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology. 2004;111:273-281.
20. Varoga D, Pufe T, Harder J, Schroder JM, Mentlein R, Meyer-Hoffert U, Goldring MB, Tillmann B, Hassenpflug J, Paulsen F: Human beta-defensin 3 mediates tissue remodeling processes in articular cartilage by increasing levels of metalloproteinases and reducing levels of their endogenous inhibitors. Arthritis Rheum. 2005;52:1736-1745.
21. Zanetti M: Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol. 2004;75:39-48.
22. Bals R, Wilson JM: Cathelicidins - a family of multifunctional antimicrobial peptides. Cell Mol Life Sci. 2003;60:711-720.
23. Sorensen, OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, Hiemstra PS, Borregaard N: Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood. 2001;97:3951-3959.
24. Sorensen OE, Gram L, Johnsen AH, Andersson E, Bangsboll S, Tjabringa GS, Hiemstra PS, Malm J, Egesten A, Borregaard N: Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin. A novel mechanism of generating antimicrobial peptides in vagina. J Biol Chem. 2003;278:28540-28546.
25. Yamasaki K, Schauber J, Coda A, Lin H, Dorschner RA, Schechter NM, Bonnart C, Descargues P, Hovnanian A, Gallo RL: Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J. 2006;20:2068-2080.
26. Putsep K, Carlsson G, Boman H, Andersson M: Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 2002;360:1144-1149.
27. de Haar SF, Hiemstra PS, van Steenbergen MT, Everts V, Beertsen W: Role of polymorphonuclear leukocyte-derived serine proteinases in defense against Actinobacillus actinomycetemcomitans. Infect Immun. 2006;74:5284-5291.
28. Tjabringa GS, Rabe KF, Hiemstra PS: The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung. Pulm Pharmacol Ther. 2005;18:321-327.
29. Gombart AF, Borregaard N, Koeffler HP: Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005;19:1067-1077.
30. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, Tavera-Mendoza L, Lin R, Hanrahan JW, Mader S, White JH: Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173:2909-2912.
31. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770-1773.
32. Weber G, Heilborn JD, Chamorro Jimenez CI, Hammarsjo A, Torma H, Stahle M: Vitamin D induces the antimicrobial protein hCAP18 in human skin. J Invest Dermatol 2005;124:1080-1082.
33. Mallbris L, Edstrom DW, Sundblad L, Granath F, Stahle M: UVB upregulates the antimicrobial protein hCAP18 mRNA in human skin. J Invest Dermatol. 2005;125:1072-1074.
34. Scott, MG, Dullaghan E, Mookherjee N, Glavas N, Waldbrook M, Thompson A, Wang A, Lee K, Doria S, Hamill P, Yu JJ, Li Y, Donini O, Guarna MM, Finlay BB, North JR, Hancock REW: An anti-infective peptide that selectively modulates the innate immune response. Nat Biotech. 2007;25:465-472.